CAR- T and mobile genetics therapies are actually too pricey

.Nature Medicine, Released online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of-care production and also technology transfer can easily supply mobile gene treatments at a cost effective cost to individuals across the world.